Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMID 24297569)

Published in Cancer Immunol Immunother on December 03, 2013

Authors

Christian J Maine1, Nor Haslinda Abdul Aziz, Jayanta Chatterjee, Claudia Hayford, Nancy Brewig, Lynsey Whilding, Andrew J T George, Sadaf Ghaem-Maghami

Author Affiliations

1: Department of Medicine, Imperial College London, London, UK.

Articles citing this

Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. Trends Mol Med (2014) 1.59

T-cell exhaustion in the tumor microenvironment. Cell Death Dis (2015) 1.32

Immune checkpoint inhibitors in clinical trials. Chin J Cancer (2014) 0.98

CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer. Cancer Immunol Res (2015) 0.93

Immune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer? Int J Mol Sci (2016) 0.90

The role of PD-L1 in the radiation response and prognosis for esophageal squamous cell carcinoma related to IL-6 and T-cell immunosuppression. Oncotarget (2016) 0.88

Immunotherapeutic approaches to ovarian cancer treatment. J Immunother Cancer (2015) 0.88

IL-27 induces the expression of IDO and PD-L1 in human cancer cells. Oncotarget (2015) 0.84

Inhibitory receptors as targets for cancer immunotherapy. Eur J Immunol (2015) 0.83

Human Cancer Immunotherapy with PD-1/PD-L1 Blockade. Biomark Cancer (2015) 0.83

The role of PD-L1 in the radiation response and clinical outcome for bladder cancer. Sci Rep (2016) 0.81

Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment. Biomolecules (2016) 0.80

Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application. Int J Clin Oncol (2016) 0.79

Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy. Cancer Immunol Res (2016) 0.79

PD-1 and its ligands are important immune checkpoints in cancer. Oncotarget (2016) 0.79

Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer. Oncotarget (2015) 0.78

Harnessing the PD-1 pathway in renal cell carcinoma: current evidence and future directions. BioDrugs (2014) 0.76

The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27. Oncoimmunology (2016) 0.76

IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination. Oncotarget (2016) 0.75

Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients. PLoS One (2017) 0.75

Cancer Vaccines in Ovarian Cancer: How Can We Improve? Biomedicines (2016) 0.75

Effects of programmed death-ligand 1 expression on OK-432 immunotherapy following transurethral resection in non-muscle invasive bladder cancer. Oncol Lett (2017) 0.75

Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma. J Gynecol Oncol (2017) 0.75

Articles by these authors

The RETINOBLASTOMA-RELATED gene regulates stem cell maintenance in Arabidopsis roots. Cell (2005) 2.77

Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res (2009) 2.32

The safety and side effects of monoclonal antibodies. Nat Rev Drug Discov (2010) 2.23

CEACAM1+ myeloid cells control angiogenesis in inflammation. Blood (2009) 1.57

Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogues. Angew Chem Int Ed Engl (2008) 1.48

Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis (2002) 1.42

Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy. Blood (2005) 1.24

Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol (2006) 1.24

Detection of vascular expression of E-selectin in vivo with MR imaging. Radiology (2006) 1.18

Optimized selective N-methylation of peptides on solid support. J Pept Sci (2006) 1.18

Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J Immunol (2005) 1.15

Osteopontin as two-sided mediator of intestinal inflammation. J Cell Mol Med (2008) 1.14

Inflammatory cytokines induce apoptosis of corneal endothelium through nitric oxide. Invest Ophthalmol Vis Sci (2004) 1.13

Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis. Hum Reprod Update (2013) 1.13

The effect of multiple N-methylation on intestinal permeability of cyclic hexapeptides. Mol Pharm (2011) 1.10

Expression of callose synthase genes and its connection with Npr1 signaling pathway during pathogen infection. Planta (2008) 1.06

Gene delivery by dendrimers operates via a cholesterol dependent pathway. Nucleic Acids Res (2004) 1.03

Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity? J Immunol (2013) 1.02

Endometrial cancer. BMJ (2011) 1.02

Identification of synovium-specific homing peptides by in vivo phage display selection. Arthritis Rheum (2002) 1.01

Intestinal permeability of cyclic peptides: common key backbone motifs identified. J Am Chem Soc (2012) 1.00

Oscillations in the immune system. Immunol Rev (2007) 1.00

Reconstruction of cell population dynamics using CFSE. BMC Bioinformatics (2007) 0.99

Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection. Invest Ophthalmol Vis Sci (2003) 0.99

T-lymphocyte invasiveness: control by voltage-gated Na+ channel activity. FEBS Lett (2004) 0.98

Feedback control of T-cell receptor activation. Proc Biol Sci (2004) 0.98

Solid-phase synthesis of 1,3-azole-based peptides and peptidomimetics. Org Lett (2006) 0.96

A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian masses. Gynecol Oncol (2013) 0.94

3-hydroxykynurenine suppresses CD4+ T-cell proliferation, induces T-regulatory-cell development, and prolongs corneal allograft survival. Invest Ophthalmol Vis Sci (2011) 0.93

Arginine depletion as a mechanism for the immune privilege of corneal allografts. Eur J Immunol (2011) 0.93

Gene delivery by dendrimers operates via different pathways in different cells, but is enhanced by the presence of caveolin. J Immunol Methods (2006) 0.93

A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites. Eur J Immunol (2004) 0.92

Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival. Invest Ophthalmol Vis Sci (2002) 0.92

Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction. Exp Eye Res (2005) 0.90

Effect of vectors on human endothelial cell signal transduction: implications for cardiovascular gene therapy. Arterioscler Thromb Vasc Biol (2005) 0.90

The poly(c)-binding protein-1 regulates expression of the androgen receptor. Endocrinology (2010) 0.90

Synthesis and in vitro evaluation of [18F]fluoroethyl triazole labelled [Tyr3]octreotate analogues using click chemistry. Bioorg Med Chem Lett (2011) 0.90

Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression. Blood (2005) 0.89

Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors. Cancer Immunol Immunother (2007) 0.88

Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition. Eur J Immunol (2013) 0.88

Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury. Am J Physiol Renal Physiol (2014) 0.87

A study of symptoms described by ovarian cancer survivors. Gynecol Oncol (2011) 0.86

Delivery of oligodeoxynucleotides into human saphenous veins and the adjunct effect of ultrasound and microbubbles. Ultrasound Med Biol (2005) 0.86

Regulation of rat and human T-cell immune response by pharmacologically modified dendritic cells. Transplantation (2009) 0.86

Immune modulation in corneal transplantation. Transplant Rev (Orlando) (2008) 0.85

Targeting somatostatin receptors: preclinical evaluation of novel 18F-fluoroethyltriazole-Tyr3-octreotate analogs for PET. J Nucl Med (2011) 0.84

Gene therapy for transplantation with viral vectors--how much of the promise has been realised? Expert Opin Biol Ther (2006) 0.84

Dynamic spectral imaging: improving colposcopy. Clin Cancer Res (2009) 0.84

Targeting gene delivery to activated vascular endothelium using anti E/P-Selectin antibody linked to PAMAM dendrimers. J Immunol Methods (2009) 0.83

A phase I trial of idiotypic vaccination with HMFG1 in ovarian cancer. Cancer Immunol Immunother (2004) 0.83

New perspective in peptide chemistry by N-alkylation. Adv Exp Med Biol (2009) 0.83

Early treatment with low fixed dose (5 mCi) radioiodine therapy is effective in Indian subjects with Graves' disease. J Indian Med Assoc (2008) 0.82

Xenon treatment attenuates early renal allograft injury associated with prolonged hypothermic storage in rats. FASEB J (2013) 0.82

Immunolipoplexes: an efficient, nonviral alternative for transfection of human dendritic cells with potential for clinical vaccination. Mol Ther (2005) 0.82

Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis. Arthritis Rheum (2011) 0.82

Hydrophobic modification of low molecular weight polyethylenimine for improved gene transfection. Biomaterials (2013) 0.82

Expression of the chemokine antagonist vMIP II using a non-viral vector can prolong corneal allograft survival. Transplantation (2008) 0.81

Tolerant T cells display impaired trafficking ability. Eur J Immunol (2005) 0.81

Differential effects of costimulatory pathway modulation on corneal allograft survival. Invest Ophthalmol Vis Sci (2006) 0.81

Achieving uterine auto-transplantation in a sheep model using iliac vessel anastomosis: a short-term viability study. Acta Obstet Gynecol Scand (2014) 0.81

Molecular characteristics and risk factors in endometrial cancer: what are the treatment and preventative strategies? Int J Gynecol Cancer (2010) 0.81

Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: expression, design optimization, uptake mechanism and nuclear localization. Nucleic Acids Res (2009) 0.80

The DNA methylomes of serous borderline tumors reveal subgroups with malignant- or benign-like profiles. Am J Pathol (2013) 0.80

Can N-methylated amino acids serve as substitutes for prolines in conformational design of cyclic pentapeptides? J Pept Sci (2009) 0.80

Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice. Am J Pathol (2010) 0.79

Risk of Ovarian Cancer Relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancer. Int J Gynecol Cancer (2015) 0.78

Positive pre-resection pleural lavage cytology is associated with increased risk of lung cancer recurrence in patients undergoing surgical resection: a meta-analysis of 4450 patients. Thorax (2012) 0.78

Chemical activators of protein phosphatase-1 induce calcium release inside intact cells. Chem Biol (2013) 0.78

Long-term compliance with follow-up after treatment for cervical intra-epithelial neoplasia. Acta Obstet Gynecol Scand (2012) 0.78

Suppression of the allogeneic response by the anti-allergy drug N-(3,4-dimethoxycinnamonyl) anthranilic acid results from T-cell cycle arrest. Immunology (2013) 0.77

Xenon Treatment Protects against Remote Lung Injury after Kidney Transplantation in Rats. Anesthesiology (2015) 0.77

A novel treatment strategy for ovarian cancer based on immunization against zona pellucida protein (ZP) 3. FASEB J (2011) 0.77

Knockdown of mouse VCAM-1 by vector-based siRNA. Transpl Immunol (2006) 0.77

Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with Carboplatin. J Immunol (2013) 0.77

Anti-LFA-1 monotherapy prevents neointimal formation in a murine model of transplant intimal hyperplasia. J Heart Lung Transplant (2007) 0.77

Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism. Cytotherapy (2011) 0.77

A study to evaluate the cause of bone demineralization in gynecological cancer survivors. Oncologist (2013) 0.77

A novel strategy for preserving renal grafts in an ex vivo setting: potential for enhancing the marginal donor pool. FASEB J (2013) 0.76

Test of long-term uterine survival after allogeneic transplantation in rabbits. J Obstet Gynaecol Res (2013) 0.76

The impact of amino acid side chain mutations in conformational design of peptides and proteins. Chemistry (2010) 0.76

Transfection of indoleamine 2,3 dioxygenase in primary endothelial cells. Methods Mol Biol (2010) 0.76

Use of cyclosporine in uterine transplantation. J Transplant (2011) 0.75

Referrals to secondary care. Referral rates for postmenopausal bleeding are not respectable. BMJ (2010) 0.75

Horner's syndrome with epidural anaesthesia. BMJ Case Rep (2010) 0.75

We need time for training. Br J Hosp Med (Lond) (2010) 0.75

Radical trachelectomy: need for a randomized controlled trial? Acta Obstet Gynecol Scand (2011) 0.75

Changing viral tropism using immunoliposomes alters the stability of gene expression: implications for viral vector design. Mol Med (2007) 0.75

Dharmasena case illustrates what is wrong with complaints procedures. BMJ (2015) 0.75

Uterus transplantation in the human: a complex surgical, medical and ethical challenge. Hum Reprod (2012) 0.75

Trachelectomy during pregnancy: what has experience taught us? J Obstet Gynaecol Res (2014) 0.75

Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells. Mol Ther (2017) 0.75

Gene therapy for clinical transplantation: where do we stand in 2006? Discov Med (2006) 0.75

Making double-minded peptides strong-willed? The side chain impact on the backbone conformation of N-methylated cyclic pentapeptides. Adv Exp Med Biol (2009) 0.75

Immunology of uterine transplantation: a review. Reprod Sci (2011) 0.75